Literature DB >> 2316786

Effect of mass treatment of a human population with ivermectin on transmission of Onchocerca volvulus by Simulium yahense in Liberia, West Africa.

M Trpis1, J E Childs, D J Fryauff, B M Greene, P N Williams, B E Munoz, M C Pacque, H R Taylor.   

Abstract

The impact of mass treatment with ivermectin on the intensity of Onchocerca volvulus transmission by the black fly (Simulium yahense) was evaluated on the Liberian Agricultural Company rubber plantation in Liberia, West Africa. The adult pre-treatment prevalence of onchocerciasis was greater than 80%, and the average intensity of infection was 5.35 mf/mg of skin. The drug was administered at 2 annual intervals, reaching 58-60% of the approximately 14,000 people living in 73 camps. Landing/biting catches of black flies made in central and peripheral plantation zones indicated similar fly activity before and after ivermectin treatment (man hr index of 2.1 and 2.4 within the plantation, and 10 and 10.9 outside the plantation, respectively). The number of infected flies with developing larvae (L1, L2, L3 stages) of O. volvulus in treated areas was reduced by 93.4-95%; the number of infective flies with L3 larvae was reduced by 81.7-89.3%. Parasite loads of infected (L1, L2) and infective flies (L3 stages only) outside the plantation also decreased by 86.8% and 80%, respectively. Monthly transmission potential (MTP) showed a similar decrease: from 22.9 to 5.8 (74.6% reduction) in the treated area, and from 210 to 158.8 (24.4% reduction) in untreated areas. Mass treatment with ivermectin efficiently controlled, and at least temporarily interrupted, transmission of Onchocerca volvulus by black fly vectors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2316786     DOI: 10.4269/ajtmh.1990.42.148

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  7 in total

Review 1.  Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis.

Authors:  K L Goa; D McTavish; S P Clissold
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

2.  Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea.

Authors:  P Guillet; A Sékétéli; E S Alley; H Agoua; B A Boatin; Y Bissan; L K Akpoboua; D Quillévéré; E M Samba
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

Review 3.  Ivermectin for onchocercal eye disease (river blindness).

Authors:  Henry O D Ejere; Ellen Schwartz; Richard Wormald; Jennifer R Evans
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 4.  Onchocerciasis.

Authors:  H R Taylor
Journal:  Int Ophthalmol       Date:  1990-05       Impact factor: 2.031

5.  Evaluation of Community-Directed Operation of Black Fly Traps for Entomological Surveillance of Onchocerca volvulus Transmission in the Madi-Mid North Focus of Onchocerciasis in Northern Uganda.

Authors:  Denis Loum; Charles R Katholi; Thomson Lakwo; Peace Habomugisha; Edridah M Tukahebwa; Thomas R Unnasch
Journal:  Am J Trop Med Hyg       Date:  2017-10       Impact factor: 3.707

6.  The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon.

Authors:  Raphael Awah Abong; Glory Ngongeh Amambo; Ali Ahamat Hamid; Belinda Agbor Enow; Amuam Andrew Beng; Franck Noel Nietcho; Theobald Mue Nji; Abdel Jelil Njouendou; Manuel Ritter; Mathias Eyong Esum; Kebede Deribe; Jerome Fru Cho; Fanny Fri Fombad; Peter Ivo Enyong; Catherine Poole; Kenneth Pfarr; Achim Hoerauf; Clotilde Carlow; Samuel Wanji
Journal:  PLoS Negl Trop Dis       Date:  2021-01-19

7.  Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.

Authors:  Lamine Diawara; Mamadou O Traoré; Alioune Badji; Yiriba Bissan; Konimba Doumbia; Soula F Goita; Lassana Konaté; Kalifa Mounkoro; Moussa D Sarr; Amadou F Seck; Laurent Toé; Seyni Tourée; Jan H F Remme
Journal:  PLoS Negl Trop Dis       Date:  2009-07-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.